Acting in an ethical and responsible manner for the patient

Sanofi-aventis acts in an ethical and responsible manner to be a true healthcare partner, today and tomorrow. Our sustainability approach places the patient at the center of our business conduct. It is based on 4 key areas: Patient 21, People 21, Ethics 21 and Planet 21, which are in line with the « Agenda 21 » of the United Nations.

Zoom

Access to medicines

Most of the global population has little or no access to the most basic medicines. In response to this issue, sanofi-aventis has taken proactive steps to make access to healthcare an important part of our strategy for people living in developing as well as industrialized countries.

• For more information about access to medicines in developing countries
• Fore more information about access to medicines in industrialized countries

Pharmaceuticals in the environment

In its commitment to sustainable development, the sanofi-aventis Group has initiated programs to improve risk assessments and considers this challenge to be a priority.

• For more information about pharmaceuticals in the environment

Innovation and ethics in R&D

Conducting research in a context of transparency, with respect for both individuals and regulations.

• For more information about innovation and ethics in R&D

Highlights

Patient associations      March 2010 Find out about our support to patient associations based in Europe

4th Provençal Day for Humanitarian Health Initiatives      November 20, 2009 Sanofi-aventis supports the 4th Provençal Day for Humanitarian Health Initiatives

• Access all the news

    September 21, 2009

• Sanofi-aventis receives renewed recognition as a leader in sustainability

The experts’ corner

Our environmental, social and economic indicators

Corporate Social Responsibility 2009 Sustainability brochure 2009 All our publications